Cardiac Risk Index

The Cardiac Risk Index refers to clinical tools used to predict the risk of major adverse cardiac events (MACE) in patients undergoing non-cardiac surgery. The most widely validated is the Revised Cardiac Risk Index (RCRI), developed by Lee et al. in 1999. Below is a structured overview:

Revised Cardiac Risk Index (RCRI)

Purpose: Stratify risk of cardiac complications (MI, pulmonary edema, VF, cardiac arrest, complete heart block) within 30 days post-surgery.

Six Predictive Criteria (1 point each):

  1. High-Risk Surgery:
    • Intraperitoneal, intrathoracic, or suprainguinal vascular procedures.
  2. History of Ischemic Heart Disease:
    • Prior MI, stable/unstable angina, or positive stress test.
  3. History of Congestive Heart Failure (CHF):
    • Current or past CHF (e.g., paroxysmal nocturnal dyspnea, S3 gallop, pulmonary edema).
  4. History of Cerebrovascular Disease:
    • Prior TIA or stroke.
  5. Diabetes Mellitus on Insulin Therapy.
  6. Preoperative Renal Insufficiency:
    • Creatinine >2.0 mg/dL (177 µmol/L).

Risk Stratification & MACE Probability:

RCRI Score
Risk of MACE
Clinical Implication
0
0.4%
Low risk
1
0.9%
Low risk
2
6.6%
Intermediate risk
≥3
>11%
High risk

Other Key Cardiac Risk Indices

  1. ACS NSQIP Surgical Risk Calculator:

    • Uses 21+ variables (age, functional status, ASA class, lab values).
    • Estimates risk of cardiac events, pneumonia, renal failure, etc.
    • Online tool: riskcalculator.facs.org.

  2. Gupta Myocardial Infarction or Cardiac Arrest (MICA) Calculator:

    • Predicts risk of MI or arrest.
    • Factors: Age, creatinine, ASA class, surgery type, functional status.

Clinical Applications

  • Preoperative Optimization:
    • High-risk patients (RCRI ≥2) may need:
      • Cardiology consultation.
      • Coronary revascularization (if indicated).
      • Beta-blockers/statins (per guidelines).
  • Intraoperative Management:
    • Goal-directed hemodynamic therapy.
    • Avoid hypotension/tachycardia.
  • Postoperative Monitoring:
    • Troponin surveillance in high-risk patients.
    • Telemetry for RCRI ≥1.

Limitations of RCRI

  • Age not included (elderly patients underestimated).
  • Functional status not captured (e.g., poor exercise tolerance).
  • Underestimates risk in vascular surgery.
  • Does not account for biomarkers (e.g., elevated BNP/NT-proBNP).

Key Considerations for Anesthesia Trainees

  1. RCRI is a starting point, not a definitive tool. Combine with clinical judgment.
  2. Assess functional status:
    • Can the patient climb 2 flights of stairs (≥4 METs)?
  3. Biomarkers add value:
    • Elevated preoperative BNP/NT-proBNAP predicts MACE independently.
  4. Perioperative beta-blockers:
    • Continue in patients already on them.
    • Avoid initiating high-dose beta-blockers acutely (risk of stroke).
  5. Statins:
    • Continue perioperatively (cardioprotective).

Summary

The RCRI remains the cornerstone for cardiac risk stratification in non-cardiac surgery. A score ≥2 warrants multidisciplinary planning. Always integrate it with patient-specific factors (frailty, functional capacity, biomarkers) for personalized perioperative care.

References:

  • Lee TH, et al. Circulation. 1999;100:1043-1049.
  • Fleisher LA, et al. JACC. 2014;64(22):e77-e137. (ACC/AHA Guidelines)

Comments are closed.